Wendy Sonnet, Clinical Operations Manager at InhaTarget Therapeutics

Wendy Sonnet

Clinical Operations Manager at InhaTarget Therapeutics | Genappe, Walloon Region, Belgium

Profile last verified September 2026
Pharmaceuticals Verified Profile Genappe, Walloon Region, Belgium Université catholique de Louvain
Verified

Work Email

***@inhatarget.com

Last verified October 2026

Phone Number

+32*****

Belgium • Mobile

Free account · No credit card · 5 profiles/month

Wendy Sonnet Socials
Wendy Sonnet Work Experience

Clinical Operations Manager at InhaTarget Therapeutics in December 2021 - Present

Regulatory Affairs Manager at BONE THERAPEUTICS S.A. in February 2021 - December 2021

Clinical Operations Manager at BONE THERAPEUTICS S.A. in February 2016 - January 2021

See more See less

Clinical Project Manager at BONE THERAPEUTICS S.A. in October 2013 - January 2016

Data Integration Specialist at Business & Decision Life Sciences in July 2013 - October 2013

Researcher in early development and molecular biology at Université catholique de Louvain in October 2007 - June 2012

Wendy Sonnet Education

Université catholique de Louvain, PhD in Sciences, January 2007 to January 2012

Université catholique de Louvain, Master's degree, January 2003 to January 2007

Université Laval, International exchange (4 months), January 2006

Wendy Sonnet Skills
In vitro production of mammalian embryos Cell Biology Molecular Biology Scientific Writing Communication Skills Project Management Cell Culture Research Clinical Trials Lifesciences
About Wendy Sonnet’s Current Company
InhaTarget Therapeutics

InhaTarget Therapeutics develops innovative and targeted dry powders for inhalation (“DPI”) that aim to improve the treatmentsof respiratory diseases, with a particular focus on lung cancer Capitalizing on its advanced expertise in pulmonary drug delivery (especially in DPI), InhaTarget Therapeutics organizes its activities under two strands: 1. The early development of proprietary products (phase I/II) to be licensed to pharmaceutical partners. InhaTarget therapeutics wants to focus on its core competencies (R&D and clinical proof-of concept) to deliver proven high-quality products to a pharma partner which will be in charge of the conduct of later clinical studies, regulatory approvals and marketing and sales. Aware of the challenging specificities of the production processes and equipment for high potency compounds, InhaTarget therapeutics may take care of the GMP production of the DPI products (both the samples for clinical trials and the commercial products). 2. The custom development requested by pharmaceutical companies of innovative products for inhalation in different indications (infections, asthma, COPD, etc.), from the pre-formulation to the clinical proof-of-concept. Using the keen expertise of the team and its specialized equipment, InhaTarget Therapeutics develops, in collaboration with interested pharma partners, innovative DPIs. It does so using particle engineering techniques that are scalable, such as high-pressure homogenization and spray-drying and that, preferably, use approved, endogenous or well-tolerated excipients. The services of InhaTarget therapeutics on lung drug delivery range from in vitro evaluation, to the evaluation of new excipients and/or devices, particle engineering and production methods using novel processes and aerosol formulations, and finally to preclinical studies in different animal models, in vivo evaluation of lung deposition in humans, local and systemic drug bioavailability, and clinical outcomes.

Discover more about InhaTarget Therapeutics
Wendy Sonnet’s Colleagues
Eric Leire

Eric Leire

Brussels Metropolitan Area

CEO Genflow Biosciences

Non Executive Director at InhaTarget Therapeutics
(Aug 2020 – Present)

Abdallah Ladaycia

Abdallah Ladaycia

Brussels, Brussels Region, Belgium

R&D Formulation Lead, PhD, PharmD.

R&D Formulation Lead at InhaTarget Therapeutics
(Jan 2026 – Present)

Baptiste Mingers

Baptiste Mingers

Brussels Metropolitan Area

Technicien analytique chez InhaTarget Therapeutics

Technicien analytique at InhaTarget Therapeutics
(Oct 2021 – Present)

Camille Rusch

Camille Rusch

Strasbourg, Grand Est, France

M.Sc. Student in Biotechnology (ESBS) & Chemical Engineering (ECPM) | Driven to contribute to innovative Medical Research

In Vitro Scientist Intern | Innovative Inhalation Therapeutics for Lung Diseases at InhaTarget Therapeutics
(Apr 2026 – Present)

Pauline Lehebel

Pauline Lehebel

Brussels Metropolitan Area

Non-Clinical Operations Lead at Inhatarget Therapeutics

Non-Clinical Operations Lead at InhaTarget Therapeutics
(Mar 2025 – Present)

FC

Frederic Coninck

Brussels Metropolitan Area

Co-founder & CEO at InhaTarget Therapeutics

Co-founder & CEO at InhaTarget Therapeutics
(Aug 2019 – Present)

Search similar profiles
Frequently asked questions about Wendy Sonnet

What is Wendy Sonnet email address?

Email Wendy Sonnet at [email protected]. This email is the most updated Wendy Sonnet's email found in 2026.

How to contact Wendy Sonnet?

To contact Wendy Sonnet send an email to [email protected].

What company does Wendy Sonnet work for?

Wendy Sonnet works for InhaTarget Therapeutics.

What is Wendy Sonnet's role at InhaTarget Therapeutics?

Wendy Sonnet is Clinical Operations Manager

What industry does Wendy Sonnet work in?

Wendy Sonnet works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free